I am a
Home I AM A Search Login

Papers of the Week

2019 Aug

Eur J Gastroenterol Hepatol



Effectiveness of 8-week sofosbuvir/ledipasvir in the adolescent chronic hepatitis C-infected patients.


El-Khayat H, Kamal EM, Yakoot M, Gawad MA, Kamal N, El Shabrawi M, Sameh Y, Haseeb A, Fouad Y, Attia D
Eur J Gastroenterol Hepatol. 2019 Aug; 31(8):1004-1009.
PMID: 30676473.


The sustained virological response (SVR) rate for the 12-week sofosbuvir (SOF)/ledipasvir (LVD) treatment of adolescent genotype-4 patients is high. The aim of this study is to evaluate 8 versus 12-week treatment efficacy and safety in adolescent genotype-4 patients.